In an animal model, caffeine has been shown to attenuate neurovascular coupling by diminishing vasodilatory responses and reducing the expected increase in cerebral blood flow during somatosensory stimulation.
22 Studies of the human brain using blood oxygen level dependent functional magnetic resonance imaging (BOLD-fMRI) and electroencephalogram (EEG) showed that caffeine uncoupled the relationship between cerebral neuronal activity or metabolic rate of oxygen consumption (CMRO
2) and cerebral blood flow (CBF).
24,25 In normal conditions, CMRO
2 and CBF increase together, because increased neuronal metabolic demand leads to increased blood flow through neurovascular coupling.
24,25 After consumption of caffeine, CMRO
2 on fMRI and neuronal activity on EEG increase due to the neurostimulatory effect of adenosine A1 receptor inhibition.
23–25 However, instead of an expected compensatory increase in blood flow, caffeine causes decreased CBF due to the vasoconstrictive effects of adenosine A2a receptor inhibition, leading to potential relative ischemia that is postulated to be salvaged by increased oxygen extraction in the brain.
23–25,37 The localization and relative proportion of these adenosine receptors could reflect the topographical distribution of vascular response to caffeine in the central nervous system.
23 In the human retina, both adenosine A1 and A2a receptors are present,
38 which could mediate similar caffeine effects in the eye as in the brain, namely a state of heightened neuronal activity but relative vasoconstriction. Because inhibition of A1 produces neurostimulatory effects in the brain,
23–25 the delay in retinal vascular responses during dark to light transition is better explained by delayed neurovascular responses rather than an appropriate vascular response to decreased metabolic demand after caffeine intake. Ultimately, the disruption of neurovascular coupling could potentially lead to inadequate distribution of blood flow to retinal neurons.